LivaNova PLC (NASDAQ:LIVN) Receives Consensus Recommendation of “Moderate Buy” from Analysts

LivaNova PLC (NASDAQ:LIVN) has been given an average recommendation of “Moderate Buy” by the eleven analysts that are covering the stock, MarketBeat.com reports. Four investment analysts have rated the stock with a hold recommendation, six have assigned a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1-year price target among analysts that have covered the stock in the last year is $81.3750.

Several equities analysts have recently commented on the company. Barclays upped their price target on LivaNova from $73.00 to $76.00 and gave the company an “equal weight” rating in a research note on Thursday, May 7th. Weiss Ratings raised shares of LivaNova from a “sell (d+)” rating to a “hold (c)” rating in a research report on Thursday, May 7th. Robert W. Baird dropped their price target on shares of LivaNova from $78.00 to $76.00 and set an “outperform” rating for the company in a research report on Thursday, May 7th. KeyCorp upped their price objective on shares of LivaNova from $83.00 to $92.00 and gave the stock an “overweight” rating in a report on Monday, June 22nd. Finally, Mizuho boosted their target price on LivaNova from $90.00 to $95.00 and gave the company an “outperform” rating in a research report on Wednesday, July 15th.

LivaNova Trading Down 1.1%

Shares of LIVN stock opened at $80.14 on Friday. The company has a current ratio of 1.33, a quick ratio of 1.11 and a debt-to-equity ratio of 0.24. LivaNova has a twelve month low of $41.01 and a twelve month high of $85.27. The company’s 50-day moving average price is $79.09 and its 200-day moving average price is $70.13. The stock has a market cap of $4.40 billion, a price-to-earnings ratio of 41.10 and a beta of 0.86.

LivaNova (NASDAQ:LIVN) last released its quarterly earnings data on Wednesday, May 6th. The company reported $0.98 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.85 by $0.13. The firm had revenue of $362.26 million during the quarter, compared to analysts’ expectations of $346.05 million. LivaNova had a net margin of 7.48% and a return on equity of 16.48%. LivaNova’s revenue was up 14.3% compared to the same quarter last year. During the same period last year, the business earned $0.88 earnings per share. LivaNova has set its FY 2026 guidance at 4.200-4.300 EPS. As a group, equities analysts predict that LivaNova will post 3.73 earnings per share for the current year.

Insider Activity

In related news, Director Francesco Bianchi sold 1,800 shares of LivaNova stock in a transaction that occurred on Tuesday, May 26th. The shares were sold at an average price of $75.75, for a total value of $136,350.00. Following the completion of the transaction, the director owned 7,228 shares in the company, valued at approximately $547,521. The trade was a 19.94% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 0.35% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the stock. UMB Bank n.a. increased its stake in shares of LivaNova by 22.6% during the fourth quarter. UMB Bank n.a. now owns 971 shares of the company’s stock worth $60,000 after buying an additional 179 shares during the period. State of Michigan Retirement System increased its position in shares of LivaNova by 1.5% in the 1st quarter. State of Michigan Retirement System now owns 13,111 shares of the company’s stock valued at $833,000 after purchasing an additional 200 shares during the last quarter. Hantz Financial Services Inc. increased its position in shares of LivaNova by 159.9% in the 4th quarter. Hantz Financial Services Inc. now owns 434 shares of the company’s stock valued at $27,000 after purchasing an additional 267 shares during the last quarter. GAMMA Investing LLC raised its holdings in shares of LivaNova by 18.2% in the 2nd quarter. GAMMA Investing LLC now owns 1,838 shares of the company’s stock valued at $151,000 after purchasing an additional 283 shares in the last quarter. Finally, Parallel Advisors LLC raised its holdings in shares of LivaNova by 28.8% in the 4th quarter. Parallel Advisors LLC now owns 1,266 shares of the company’s stock valued at $78,000 after purchasing an additional 283 shares in the last quarter. 97.64% of the stock is owned by institutional investors and hedge funds.

About LivaNova

LivaNova plc is a global medical technology company that develops and manufactures products and therapies for the cardiac surgery and neuromodulation markets. Headquartered in London, United Kingdom, and Houston, Texas, LivaNova serves hospitals, clinics and healthcare providers in more than 100 countries. The company’s primary focus lies in advancing patient care through innovations in heart–lung bypass, cardiac preservation, circulatory support and neurostimulation therapies.

The Cardiac Surgery business unit offers a comprehensive portfolio of products used in cardiopulmonary bypass procedures, including oxygenators, heart–lung machines, arterial filters, cannulae and sutureless heart valves.